Style | Citing Format |
---|---|
MLA | Pashangzadeh S, et al.. "Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 20, no. 9, 2020, pp. 1434-1447. |
APA | Pashangzadeh S, Yazdani R, Nazari F, Azizi G, Abolhassani H, Aghamohammadi A (2020). Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Endocrine# Metabolic and Immune Disorders - Drug Targets, 20(9), 1434-1447. |
Chicago | Pashangzadeh S, Yazdani R, Nazari F, Azizi G, Abolhassani H, Aghamohammadi A. "Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management." Endocrine# Metabolic and Immune Disorders - Drug Targets 20, no. 9 (2020): 1434-1447. |
Harvard | Pashangzadeh S et al. (2020) 'Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management', Endocrine# Metabolic and Immune Disorders - Drug Targets, 20(9), pp. 1434-1447. |
Vancouver | Pashangzadeh S, Yazdani R, Nazari F, Azizi G, Abolhassani H, Aghamohammadi A. Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2020;20(9):1434-1447. |
BibTex | @article{ author = {Pashangzadeh S and Yazdani R and Nazari F and Azizi G and Abolhassani H and Aghamohammadi A}, title = {Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {20}, number = {9}, pages = {1434-1447}, year = {2020} } |
RIS | TY - JOUR AU - Pashangzadeh S AU - Yazdani R AU - Nazari F AU - Azizi G AU - Abolhassani H AU - Aghamohammadi A TI - Agammaglobulinemia: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 20 IS - 9 SP - 1434 EP - 1447 PY - 2020 ER - |